Tomuzotuximab (Anti-ERBB1 / EGFR / HER1)

Tomuzotuximab (Anti-ERBB1 / EGFR / HER1) is a fully human glycoengineered IgG1 monoclonal antibodytargeting EGFR. It has anticancer effects. MW :150 KD.
Supplier Selleck Chemicals
Product # A3080
Sku # A3080-1mg*25
Pricing 1mg*25, $5070.00
Feedback